PTC Therapeutics Announces Initiation of FIREFISH Study in Infant (Type I) SMA Patients
PTC Therapeutics, Inc. announced that its joint development program in Spinal Muscular Atrophy (SMA) with Roche and the SMA Foundation (SMAF) initiated a clinical study in infants with…
Read More...
Read More...